{"organizations": [], "uuid": "49c1f34e50a6192d0987ba99a6b8196467fcd780", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180507.html", "section_title": "Archive News &amp; Video for Monday, 07 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-dar-bioscience-enters-into-agreeme/brief-dar-bioscience-enters-into-agreement-to-acquire-product-to-address-vulvar-and-vaginal-atrophy-in-hormone-receptor-positive-breast-cancer-patients-idUSASC0A01X", "country": "US", "domain_rank": 408, "title": "Daré Bioscience Enters Into Agreement To Acquire Product To Address Vulvar And Vaginal Atrophy In Hormone Receptor-Positive Breast Cancer Patients", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.999, "site_type": "news", "published": "2018-05-07T20:10:00.000+03:00", "replies_count": 0, "uuid": "49c1f34e50a6192d0987ba99a6b8196467fcd780"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-dar-bioscience-enters-into-agreeme/brief-dar-bioscience-enters-into-agreement-to-acquire-product-to-address-vulvar-and-vaginal-atrophy-in-hormone-receptor-positive-breast-cancer-patients-idUSASC0A01X", "ord_in_thread": 0, "title": "Daré Bioscience Enters Into Agreement To Acquire Product To Address Vulvar And Vaginal Atrophy In Hormone Receptor-Positive Breast Cancer Patients", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "dare bioscience inc", "sentiment": "negative"}, {"name": "uct", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "bioscience inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 7 (Reuters) - Dare Bioscience Inc:\n* DARÉ BIOSCIENCE, INC. ENTERS INTO AGREEMENT TO ACQUIRE PRODUCT TO ADDRESS VULVAR AND VAGINAL ATROPHY IN HORMONE RECEPTOR-POSITIVE BREAST CANCER PATIENTS\n* DARE BIOSCIENCE INC - DARÉ HAS ENTERED INTO AGREEMENT TO SECURE RIGHTS, CURRENTLY OWNED BY PEAR TREE, TO DEVELOP PT-101 Source text for Eikon:\nOur ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-07T20:10:00.000+03:00", "crawled": "2018-05-08T16:52:22.017+03:00", "highlightTitle": ""}